Task: Answer the multiple-choice question.
Question: Which compound exhibits a -10.809% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cc1ccc(NC(=O)c2ccc(-c3nn(C)c(=O)c4ccccc34)cc2)cc1
b) CN(C)C(=O)Oc1ccc(OC(=O)N(C)C)cc1
c) O=C(c1ccc2nc(N3CCOCC3)sc2c1)N1CCCC1
Answer: c. O=C(c1ccc2nc(N3CCOCC3)sc2c1)N1CCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(c1ccc2nc(N3CCOCC3)sc2c1)N1CCCC1
O=C(c1ccc2nc(N3CCOCC3)sc2c1)N1CCCC1
(2-morpholin-4-yl-1,3-benzothiazol-6-yl)-pyrrolidin-1-ylmethanone